首页|匹伐他汀与普伐他汀对急性心肌梗塞患者的心血管事件影响比较分析

匹伐他汀与普伐他汀对急性心肌梗塞患者的心血管事件影响比较分析

扫码查看
目的:分析急性心肌梗死患者应用不同类型他汀类药物匹伐他汀和普伐他汀的疗效。方法将120例首次发生心肌梗死患者随机分为匹伐他汀2mg组(n=61)和普伐他汀10mg组(n=59),进行12个月的随访观察,检测LDL胆固醇等血脂指标,并观察治疗后冠心病、脑卒中、非致死性心肌梗塞等心血管事件。结果匹伐他汀组比普伐他汀组降低LDL胆固醇水平更加明显,但普伐他汀组比匹伐他汀组显著降低急性冠脉综合征发生率。结论匹伐他汀可明显降低急性心肌梗塞发病后患者LDL胆固醇和总胆固醇,而普伐他汀则在降低心肌梗塞、心肌缺血和非致死性中风等心血管事件发生风险更为明显。
Comparison of therapeutic effects of pitavastatin and pravastatin after acute myocardial infarction
Objective This analysis compared the efficacy of pitavastatin to pravastatin in post-acute myocardial infarction patients. Methods 120 of acute myocardial infarction patients were randomly divided into two groups which were received pitavastatin(2mg/d) and pravastatin(10mg/d), After 12 months of follow-up visit, LDL was measured and coronary artery disease,myocardial infarction and acute coronary syndromewere observed. Results There was no difference in baseline LDL-C concentrations between the 2 groups. Although LDL-C was decreased more potently in the pitavastatin than pravastatin groups, acute coronary syndrome events tended to occur less frequently in the pravastatin than pitavastatin groups. Conclusion In Chinese patients after acute myocardial infarction, pitavastatin provided significantly greater LDL-C and TC reductions from base-line to 12 months, but pravastatin could be superior to lipophilic statins at reducing cardiovascular events.

PitavastatinPravastatinAcute myocardial infarctionCoronary syndrome

刘启方

展开 >

550002 贵阳,贵州省人民医院心内科

匹伐他汀 普伐他汀 急性心肌梗塞 冠状动脉综合征

2013

中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
年,卷(期):2013.(17)
  • 1
  • 5